Takeda sheds products in emerging markets in $200m deal 15-Oct-2019 By Ben Hargreaves Takeda has sold selected prescription and OTC products to Acino covering its Near East, Middle East and Africa portfolio, as it looks to trim down its portfolio following the acquisition of Shire.